Melanocortin receptor-specific compounds
US7456184B2 · kind B2 · utility
14Cited by
54References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 30, 2004 |
| Grant date | Nov 25, 2008 |
| Priority date | — |
| Expiry date | Jan 1, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A melanocortin receptor-specific compound of the general formula of structure I:where X, R1, R2a, R2b, R3, R4a, R4b, R5a and R5b are as defined in the specification, which compound binds with high affinity to one or more melanocortin receptors and is optionally an agonist, an antagonist, an inverse agonist or an antagonist of an inverse agonist, and may be employed for treatment of one or melanocortin receptor-associated conditions or disorders, and methods for the use of the compounds of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.